Collective research on the genetic and mechanistic abilities of the probiotic DE111® has been published in Frontiers of Microbiology. This work, entitled “In vitro and in silico assessment of probiotic and functional properties of Bacillus subtilis DE111®”, supports the demonstration…
KENNESAW, GA (August 2, 2021) - Deerland Probiotics & Enzymes has announced the publication of a new study that is the first of its kind to directly investigate the germination of a spore-forming probiotic strain in the human small intestines.…
While probiotic spores can confer health benefits, it is believed that germination of the spores is required for some probiotic activity (i.e. short chain fatty acids, antimicrobial peptides, enzymes, etc.). A novel clinical trial in 11 ileostomy participants was conducted…
Deerland Probiotics and Enzymes has announced the publication of a clinical study showing that the administration of the probiotic Bacillus subtilis DE111 can modify the composition of the microbiome in preschool-aged children. The study, “Daily intake of probiotic strain Bacillus subtilis DE111 supports a…
In a study involving 81 children aged 2 to 6, researchers found that that daily consumption of the probiotic strain Bacillus subtilis DE111 supported a healthy gastrointestinal tract with a reduced duration of vomiting, hard stools, and overall gastrointestinal discomfort. VIEW PUBLISHED…
In a study involving male collegiate athletes during offseason training, researchers found that DE111 (1 billion CFU), in conjunction with adequate post-workout nutrition, can promote tissue recovery and reduce likelihood of injury. The results of the study showed that compared…
A clinical study evaluating the effect of DE111 on digestive health resulted in a significant influence on gut microbiota measured prior to and after capsule consumption (5 billion CFU). Fecal samples showed an increase in the levels of B. subtilis…
